Americium Systemic Biokinetic Model for Rats

Area of Science:

• Radiopharmaceutical chemistry
• Pharmacokinetics
• Computational toxicology

Background:

• Understanding americium (Am) distribution is crucial for assessing internal contamination risks.
• Existing models may lack precision in early-phase kinetics and extrapolation.

Purpose of the Study:

• To develop a baseline compartmental model for americium distribution and retention in rats.
• To establish a foundation for evaluating decorporation therapies, such as DTPA.

Main Methods:

• A pharmacokinetic (PK)-front-end modeling approach was employed.
• Transfer rates to/from extracellular fluids (ECF) were defined by vascular flow and ECF volumes.
• Cellular transport rates were empirically determined.
• Markov chain Monte Carlo (MCMC) methods assessed uncertainties in transfer rates.

Main Results:

• The model accurately describes americium behavior in rats for the first 28 days post-intake.
• Rapid transfer of americium from ECF to liver and bone was demonstrated.
• The combined PK-front-end and empirical back-end model allowed for low-uncertainty extrapolation to early time points.

Conclusions:

• The derived compartmental model provides a robust baseline for americium kinetics.
• This model facilitates future research on decorporation agents like DTPA.
• The study highlights the utility of integrated PK and empirical modeling for radionuclide biokinetics.